Literature DB >> 22251530

Characteristics of serious complicated gastroduodenal ulcers in Japan.

Shigenao Ishikawa1, Tomoki Inaba, Motowo Mizuno, Yasuhiro Miyake, Hiroyuki Okada, Hisashi Ishikawa, Keisuke Hori, Masaki Wato, Kozo Kawai, Kazuhide Yamamoto.   

Abstract

BACKGROUND/AIMS: Even in Japan where the incidence of H. pylori infection is high, patients with gastroduodenal ulcers caused by NSAIDs are on the increase. A prospective study was conducted to elucidate the characteristics of gastroduodenal ulcers complicated with ulcerous hemorrhage and perforation among Japanese.
METHODOLOGY: The subjects were 305 consecutive cases with hemorrhaging ulcers and 76 consecutive cases with perforated ulcers basis at Kagawa Prefectural Central Hospital between January 2000 and December 2008. These subjects were divided into 3 groups (lowdose aspirin, non-aspirin NSAIDs and non-NSAIDs) and were further stratified by the presence of an H. pylori infection.
RESULTS: The 76 perforating ulcers were composed of 54 non-NSAIDs ulcers and 22 NSAIDs-related ulcers. The 305 hemorrhaging ulcers were composed of 156 non-NSAIDs ulcers, 94 non-aspirin NSAIDs ulcers and 55 on low-dose aspirin. The mortality for the non-aspirin NSAIDs group (12.8%, 12/94) and for the low-dose aspirin group (10.9%, 6/55) was significantly higher (p<0.01 and p<0.05, respectively) than the corresponding figure (2.6%, 4/156) for the non-NSAIDs group. The causes of death were exacerbation of or complications from the background diseases (Charlson Co-morbidity Index 3≤) (Odds ratios (OR) 6.01, 95% CI (1.98-18.89)).
CONCLUSIONS: Approximately 50% of the gastroduodenal ulcers with complications found in Japanese are NSAIDs-related and may take a fatal turn. It is necessary to take measures to prevent the complicated ulcers corresponding to risk factors such as the severity of background diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22251530     DOI: 10.5754/hge09689

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  5 in total

1.  Cost-Effectiveness of Proton Pump Inhibitor Co-Therapy in Patients Taking Aspirin for Secondary Prevention of Ischemic Stroke.

Authors:  Nobuyoshi Takabayashi; Kyoko Murata; Shiro Tanaka; Koji Kawakami
Journal:  Pharmacoeconomics       Date:  2015-10       Impact factor: 4.981

Review 2.  Perforated peptic ulcer.

Authors:  Kjetil Søreide; Kenneth Thorsen; Ewen M Harrison; Juliane Bingener; Morten H Møller; Michael Ohene-Yeboah; Jon Arne Søreide
Journal:  Lancet       Date:  2015-09-26       Impact factor: 79.321

3.  Resuming aspirin in patients with non-variceal upper gastrointestinal bleeding: a systematic review and meta-analysis.

Authors:  Jana G Hashash; Roni Aoun; Nadim El-Majzoub; Assem Khamis; Don Rockey; Elie A Akl; Kassem Barada
Journal:  Ann Gastroenterol       Date:  2021-03-23

4.  Prevalence of H. Pylori in Perforated Peptic Ulcer Disease at Saint Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.

Authors:  Mekdim Tadesse; Eyasu Musie; Berhanetsehay Teklewold; Endalkachew Hailu
Journal:  Ethiop J Health Sci       Date:  2021-09

5.  Operative versus non-operative management for perforated peptic ulcer disease.

Authors:  Sapna Gupta; Awad Ali Alawad; Kimberly Dacosta; Adel Mahmoud; Taghreed Mohammed
Journal:  Ann Med Surg (Lond)       Date:  2022-09-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.